Connection

JEFFREY J TARRAND to Cross Infection

This is a "connection" page, showing publications JEFFREY J TARRAND has written about Cross Infection.
Connection Strength

0.948
  1. Current microbiology of percutaneous endoscopic gastrostomy tube (PEG tube) insertion site infections in patients with cancer. Support Care Cancer. 2011 Aug; 19(8):1267-71.
    View in: PubMed
    Score: 0.273
  2. Cluster and sporadic cases of herbaspirillum species infections in patients with cancer. Clin Infect Dis. 2015 Jan 01; 60(1):48-54.
    View in: PubMed
    Score: 0.086
  3. Review of streptococcal bloodstream infections at a comprehensive cancer care center, 2000-2011. J Infect. 2013 Feb; 66(2):136-46.
    View in: PubMed
    Score: 0.076
  4. Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: a multi-state report. Am J Infect Control. 2011 Aug; 39(6):521-4.
    View in: PubMed
    Score: 0.068
  5. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant. 2010 Sep; 16(9):1265-71.
    View in: PubMed
    Score: 0.063
  6. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002). Medicine (Baltimore). 2005 Sep; 84(5):303-312.
    View in: PubMed
    Score: 0.046
  7. Hospitalization of an oncology patient suspected of having severe acute respiratory syndrome: a setup for an infection control quagmire at a comprehensive cancer center. Cancer. 2003 Dec 15; 98(12):2738-9.
    View in: PubMed
    Score: 0.041
  8. Current spectrum of bacterial infections in patients with cancer. Clin Infect Dis. 2003 Oct 15; 37(8):1144-5.
    View in: PubMed
    Score: 0.040
  9. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol. 2002 Sep; 23(9):532-7.
    View in: PubMed
    Score: 0.037
  10. Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity. Infect Control Hosp Epidemiol. 2002 Sep; 23(9):542-5.
    View in: PubMed
    Score: 0.037
  11. Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre. J Hosp Infect. 2002 May; 51(1):52-8.
    View in: PubMed
    Score: 0.037
  12. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol. 2002 Jan; 23(1):41-3.
    View in: PubMed
    Score: 0.036
  13. Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol. 2000 Mar; 21(3):226-8.
    View in: PubMed
    Score: 0.031
  14. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol. 1992 Apr; 13(4):215-21.
    View in: PubMed
    Score: 0.018
  15. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med. 2011 Feb; 39(2):245-51.
    View in: PubMed
    Score: 0.017
  16. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control. 2009 Nov; 37(9):741-5.
    View in: PubMed
    Score: 0.015
  17. Legionella pneumonia in cancer patients. Medicine (Baltimore). 2008 May; 87(3):152-159.
    View in: PubMed
    Score: 0.014
  18. Microbial contamination of hematopoietic progenitor cell products: clinical outcome. Bone Marrow Transplant. 2007 Aug; 40(4):365-8.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.